ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/02/02 | 2,255 | 2,261 | 2,205 | 2,230 | -15 | -0.7% | 966,100 |
2021/02/01 | 2,168 | 2,265 | 2,151 | 2,245 | +46 | +2.1% | 1,157,000 |
2021/01/29 | 2,339 | 2,358 | 2,165 | 2,199 | -113 | -4.9% | 2,385,800 |
2021/01/28 | 2,268 | 2,364 | 2,259 | 2,312 | -47 | -2% | 2,067,700 |
2021/01/27 | 2,290 | 2,394 | 2,281 | 2,359 | +82 | +3.6% | 2,527,600 |
2021/01/26 | 2,214 | 2,307 | 2,170 | 2,277 | +74 | +3.4% | 2,593,200 |
2021/01/25 | 2,221 | 2,260 | 2,159 | 2,203 | +24 | +1.1% | 2,428,500 |
2021/01/22 | 2,023 | 2,188 | 2,010 | 2,179 | +150 | +7.4% | 2,347,800 |
2021/01/21 | 1,999 | 2,035 | 1,975 | 2,029 | +42 | +2.1% | 1,066,700 |
2021/01/20 | 2,048 | 2,120 | 1,966 | 1,987 | +26 | +1.3% | 3,349,500 |
2021/01/19 | 1,978 | 1,983 | 1,931 | 1,961 | +4 | +0.2% | 1,011,700 |
2021/01/18 | 1,895 | 1,970 | 1,882 | 1,957 | +54 | +2.8% | 1,074,300 |
2021/01/15 | 1,877 | 1,916 | 1,847 | 1,903 | +46 | +2.5% | 909,100 |
2021/01/14 | 1,915 | 1,939 | 1,857 | 1,857 | -61 | -3.2% | 1,117,000 |
2021/01/13 | 1,870 | 1,918 | 1,860 | 1,918 | +57 | +3.1% | 912,000 |
2021/01/12 | 1,845 | 1,872 | 1,835 | 1,861 | +5 | +0.3% | 664,200 |
2021/01/08 | 1,840 | 1,872 | 1,828 | 1,856 | +40 | +2.2% | 793,900 |
2021/01/07 | 1,821 | 1,846 | 1,811 | 1,816 | -1 | -0.1% | 671,000 |
2021/01/06 | 1,787 | 1,824 | 1,765 | 1,817 | +25 | +1.4% | 606,500 |
2021/01/05 | 1,801 | 1,816 | 1,766 | 1,792 | -43 | -2.3% | 831,500 |
2021/01/04 | 1,809 | 1,835 | 1,742 | 1,835 | +27 | +1.5% | 1,233,100 |
2020/12/30 | 1,900 | 1,900 | 1,807 | 1,808 | -78 | -4.1% | 1,277,100 |
2020/12/29 | 1,853 | 1,905 | 1,842 | 1,886 | +40 | +2.2% | 1,279,100 |
2020/12/28 | 1,840 | 1,864 | 1,827 | 1,846 | -3 | -0.2% | 844,500 |
2020/12/25 | 1,825 | 1,856 | 1,808 | 1,849 | +14 | +0.8% | 736,900 |
2020/12/24 | 1,770 | 1,847 | 1,745 | 1,835 | +58 | +3.3% | 1,025,900 |
2020/12/23 | 1,734 | 1,777 | 1,708 | 1,777 | +55 | +3.2% | 1,126,400 |
2020/12/22 | 1,833 | 1,835 | 1,711 | 1,722 | -118 | -6.4% | 1,758,100 |
2020/12/21 | 1,885 | 1,909 | 1,826 | 1,840 | -23 | -1.2% | 994,900 |
2020/12/18 | 1,850 | 1,879 | 1,832 | 1,863 | +13 | +0.7% | 721,700 |
2020/12/17 | 1,853 | 1,868 | 1,827 | 1,850 | -3 | -0.2% | 672,800 |
2020/12/16 | 1,858 | 1,884 | 1,840 | 1,853 | -5 | -0.3% | 572,700 |
2020/12/15 | 1,884 | 1,888 | 1,840 | 1,858 | -15 | -0.8% | 651,200 |
2020/12/14 | 1,841 | 1,906 | 1,826 | 1,873 | +29 | +1.6% | 805,600 |
2020/12/11 | 1,824 | 1,847 | 1,814 | 1,844 | +24 | +1.3% | 870,000 |
2020/12/10 | 1,850 | 1,867 | 1,808 | 1,820 | -65 | -3.4% | 886,400 |
2020/12/09 | 1,889 | 1,889 | 1,833 | 1,885 | +6 | +0.3% | 836,200 |
2020/12/08 | 1,825 | 1,888 | 1,804 | 1,879 | +32 | +1.7% | 1,049,500 |
2020/12/07 | 1,905 | 1,919 | 1,834 | 1,847 | -72 | -3.8% | 1,311,200 |
2020/12/04 | 1,946 | 1,950 | 1,893 | 1,919 | -39 | -2% | 1,244,800 |
2020/12/03 | 1,980 | 2,014 | 1,943 | 1,958 | -31 | -1.6% | 1,085,600 |
2020/12/02 | 1,932 | 2,066 | 1,920 | 1,989 | +58 | +3% | 2,604,800 |
2020/12/01 | 1,949 | 1,964 | 1,910 | 1,931 | -17 | -0.9% | 775,100 |
2020/11/30 | 1,921 | 1,965 | 1,909 | 1,948 | +20 | +1% | 881,100 |
2020/11/27 | 1,932 | 1,965 | 1,900 | 1,928 | -9 | -0.5% | 990,700 |
2020/11/26 | 1,860 | 1,945 | 1,858 | 1,937 | +79 | +4.3% | 1,321,100 |
2020/11/25 | 1,951 | 1,963 | 1,850 | 1,858 | -100 | -5.1% | 1,806,000 |
2020/11/24 | 1,935 | 1,963 | 1,905 | 1,958 | +9 | +0.5% | 1,184,800 |
2020/11/20 | 1,940 | 1,956 | 1,925 | 1,949 | -12 | -0.6% | 754,800 |
2020/11/19 | 1,964 | 1,982 | 1,929 | 1,961 | -3 | -0.2% | 845,200 |
901~
950
件表示中 / 3553件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 285,000円 | +52.1% | +23.3% | 0.00% | 20.21倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
科研薬 | 386,000円 | +22.8% | +113.0% | 4.92% | 10.29倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 316,000円 | +14.7% | -21.6% | 1.90% | 12.35倍 | 1.00倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
持田薬 | 348,000円 | +3.0% | +27.5% | 2.30% | 22.03倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 232,400円 | +9.6% | +17.5% | 1.98% | 13.13倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム